{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/16/3312535/0/en/Outlook-Therapeutics-Announces-FDA-Acceptance-of-Resubmitted-Biologics-License-Application-for-ONS-5010-LYTENAVA-bevacizumab-vikg-as-a-Treatment-for-Wet-AMD.html", "message": "News view counter 801622 successfully enlarged"}